Fractional, Sponsor-Embedded Clinical Trial Operations
Fractional VP-level clinical operations leadership for oncology, rare disease, and Cell & gene therapy global clinical trial sponsors that need executive control without full-time overhead.
When pipeline growth starts to outpace internal infrastructure, sponsors need more than just extra hands; they require senior operational command in clinical trial operations. Embedded leadership in the form of an executive oversight team places top-tier clinical operations leadership within your organization to enhance oversight, decision-making, vendor governance, site execution, and cross-functional coordination. The goal is straightforward: create order, speed, and accountability before complexity leads to delays or unnecessary burn.
The Global Sponsor Challenge
Growth creates risk when operating discipline does not scale with it.
Many small and mid-size global sponsors reach a point where trial activity, vendor complexity, geographic spread, or portfolio expansion begin to outpace internal leadership capacity. As a result, maintaining timelines becomes increasingly difficult, and the need for robust clinical trial operations is crucial. Executive oversight of CROs and vendors diminishes, leading to longer escalations and weakened visibility.
That is where Choice ClinOps steps in as an extension of your team, providing embedded leadership to ensure smooth operations.
What Embedded ClinOps Command delivers
Executive-level sponsor-side oversight
Governance, oversight, and decision discipline
Governance, oversight, and decision discipline
Integrate senior clinical trial operations leadership into the sponsor environment through embedded leadership, ensuring executive oversight without the delay of waiting for a full-time hire.
Governance, oversight, and decision discipline
Governance, oversight, and decision discipline
Governance, oversight, and decision discipline
Enhance governance forums, improve escalation pathways, clarify ownership, and foster cross-functional coordination within clinical trial operations, supported by embedded leadership and effective executive oversight.
CRO, vendor, site network, or site governance
Governance, oversight, and decision discipline
CRO, vendor, site network, or site governance
Enhance sponsor governance across clinical trial operations, focusing on CRO and vendor selection, while ensuring strong executive oversight, accountability, and effective issue resolution through embedded leadership.
Business Process Improvement
Operational planning and execution control
CRO, vendor, site network, or site governance
We provide customized business process improvement solutions for clinical trial operations, offering embedded leadership and executive oversight that will help you streamline your processes, reduce waste, and enhance your bottom line.
Operational planning and execution control
Operational planning and execution control
Operational planning and execution control
Support milestones in clinical trial operations, ensuring enrollment readiness, budget visibility, and execution prioritization through embedded leadership and executive oversight.
Portfolio-stage flexibility
Operational planning and execution control
Operational planning and execution control
Scale clinical trial operations support based on what the program needs now, rather than what a fixed organizational chart with embedded leadership assumes, ensuring there is effective executive oversight throughout the process.
Ideal For
Ideal for global Small and mid-size clinical trial sponsors
FIH, Phase I or Phase II global oncology, rare disease, and/or cell and gene therapy clinical trial operations studies engage small and mid-size clinical trial sponsors. Before hiring full-time staff, organizations benefit from embedded leadership, ensuring effective sponsor-side governance and oversight of CROs, vendors, site networks, and sites. Experienced leaders provide governance during phase growth, pipeline development, global pipeline expansion, CRO transitions, or mergers and acquisitions. Structured execution is prioritized across lean internal teams, and processes for clinical operations team build or updates are streamlined. This approach fosters a more mature operating model without introducing permanent overhead too early. Ultimately, experienced, senior United States clinical operations leadership or governance is crucial for success.
Outcomes
Business impact
Fractional and Sponsor-Embedded Choice ClinOps Command is designed to assist sponsors in optimizing clinical trial operations by helping to:
Eliminate silos,
Remain in compliance,
Achieve study timelines,
Ensure participant safety,
Optimize resource utilization,
Strengthen execution discipline,
Improve operational efficiencies,
Reduce avoidable delay exposure,
Streamline cross-functional decisions,
Increase effective, timely communication,
Protect burn efficiency and milestone momentum, and
Enhance executive oversight to increase confidence across internal and external stakeholders.
What Makes Choice ClinOps The Obvious Choice
Why Choice ClinOps
Choice ClinOps integrates sponsor-side leadership judgment, therapeutic expertise, and budget discipline into one embedded model for clinical trial operations. This is not passive advisory work; it provides active operational command designed for high-stakes oncology, rare disease, and cell and gene therapy (CGT) clinical trial programs, ensuring robust executive oversight.
Each team member at Choice ClinOps has actively engaged in clinical operations delivery, management, and governance for over two decades across more than 30 countries, including North America, LATAM, EMEA, and APAC. We hold ourselves, our work, and our ethical standards to the highest possible level.
To maintain our innovative edge, Choice ClinOps incorporates updated technology and systems, continues to strengthen our global network and footprint, and ensures that all team members are well-educated and experienced in efficient processes and tools.
Start with a Diagnostic by Leila Cupersmith
When the science is valuable, execution cannot be left to chance.
A fast, focused assessment for sponsors seeking clarity before delay, drift, or fragmentation escalate costs in clinical trial operations.
At any stage of FIH through phase II studies—from concept to nearing closure—identify governance gaps, assess operational and execution risk, clarify priorities, and define the highest-impact next steps under executive oversight.
Study Rescue Risk Diagnostic
M&A Clinical Operations Continuity Assessment
CRO and Vendor Governance Health Check
CRO, Other Vendor, or Site Readiness Audit with a Ready-to-Execute Detailed Adjustment, Risk, and Change Management Plan
Performance Audit with a Ready-to-Execute Detailed Adjustment, Risk, and Change Management Plan
Each comprehensive diagnostic is tailored to identify the highest-priority operational risks, establish near-term action paths, and provide leadership—supported by embedded leadership—a sharper decision-making framework.
Add senior ClinOps control without adding full-time overhead
Begin with an executive exploratory meeting with Leila Cupersmith to assess how sponsor-embedded leadership in clinical trial operations can deliver the highest return for you, your clinical study team, and your company, ensuring effective executive oversight throughout the process.
Fractional, Embedded Clinical Trial Operations
Enter your email address to receive emailed clinops updates
The Global ClinOps Brief: Weekly Executive ClinOps Insights
Copyright © 2026 Choice ClinOps | Oncology, Rare Disease, & Cell and Gene Therapy Clinical Operations - All Rights Reserved.